Oncología Hepática
Queen Mary Hospital
Hong Kong, Hong KongPublikationen in Zusammenarbeit mit Forschern von Queen Mary Hospital (2)
2021
-
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Journal of Clinical Oncology, Vol. 39, Núm. 27, pp. 2991-3001
2020
-
An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise
Journal of Hepatology, Vol. 73, Núm. 4, pp. 873-881